SH2B1 variants as potential causes of non-syndromic monogenic obesity in a Brazilian cohort

• Published in: Eating and weight disorders Vol. 27; no. 8; pp. 3665 - 3674
• Main Authors: da Fonseca, Ana Carolina Proença, Assis, Izadora Sthephanie Silva, Salum, Kaio Cezar Rodrigues, Palhinha, Lohanna, Abreu, Gabriella Medeiros, Zembrzuski, Verônica Marques, Campos Junior, Mario, Nogueira Neto, José Firmino, Mattos, Fernanda Cristina C., Cambraia, Amanda, Rosado, Eliane Lopes, Maya-Monteiro, Clarissa Menezes, Cabello, Pedro Hernán, Carneiro, João Regis Ivar, Bozza, Patrícia T.
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.12.2022; Springer Nature B.V
• Subjects: Adaptor Proteins, Signal Transducing; Brazil; Cross-Sectional Studies; Female; Gastrointestinal surgery; Humans; Kinases; Medicine; Medicine & Public Health; Metabolic Syndrome; Obesity; Obesity, Morbid - genetics; Original Article; Psychiatry; Brazil; Mutations; Non-syndromic monogenic obesity; Sanger sequencing; Leptin-melanocortin pathway; Bariatric surgery; SH2B1
• ISSN: 1590-1262; 1124-4909; 1590-1262
• DOI: 10.1007/s40519-022-01506-3

Purpose SH2B1 gene encodes an important adaptor protein to receptor tyrosine kinases or cytokine receptors associated with Janus kinases. This gene has been associated with the structural and functional modulation of neurons and other cells, and impacts on energy and glucose homeostasis. Several studies suggested that alterations in this gene are strong candidates for the development of obesity. However, only a few studies have screened SH2B1 point variants in individuals with obesity. Therefore, the aim of this study was to investigate the prevalence of SH2B1 variants in a Brazilian cohort of patients with severe obesity and candidates to bariatric surgery. Methods The cohort comprised 122 individuals with severe obesity, who developed this phenotype during childhood. As controls, 100 normal-weight individuals were included. The coding region of SH2B1 gene was screened by Sanger sequencing. Results A total of eight variants were identified in SH2B1, of which p.(Val345Met) and p.(Arg630Gln) variants were rare and predicted as potentially pathogenic by the in the silico algorithms used in this study. The p.(Val345Met) was not found in either the control group or in publicly available databases. This variant was identified in a female patient with severe obesity, metabolic syndrome and hyperglycemia. The p.(Arg630Gln) was also absent in our control group, but it was reported in gnomAD with an extremely low frequency. This variant was observed in a female patient with morbid obesity, metabolic syndrome, hypertension and severe binge-eating disorder. Conclusion Our study reported for the first time two rare and potentially pathogenic variants in Brazilian patients with severe obesity. Further functional studies will be necessary to confirm and elucidate the impact of these variants on SH2B1 protein function and stability, and their impact on energetic metabolism. Level of evidence Level V, cross-sectional descriptive study.